STAT Plus: AbbVie may face fewer wrinkles after judge suggests a 10-year ban on a Botox rival
WIN MCNAMEE/GETTY IMAGES
Allergan, which AbbVie recently acquired, had alleged that two companies stole trade secrets used to develop a rival to the best-selling Botox treatment.
No hay comentarios:
Publicar un comentario